Why Eli Lilly's Stock Is Trading Higher Today

Eli Lilly LLY shares are trading higher on Monday, after the company received FDA approval for Taltz for treatment of pediatric patients with moderate to severe plaque psoriasis.

Eli Lilly is a pharmaceutical company incorporated in 1901.

Eli Lilly shares were trading up 3.1% to $138.34 at time of publication. The stock has a 52-week high of $147.87 and a 52-week low of $101.36.

Related Links:

Eli Lilly Delays New Study Starts

Eli Lilly Reports Mixed Q3 Earnings, Raises Guidance